Piper Jaffray Downgrades Gen-Probe (GPRO) to Neutral

Piper Jaffray's William Quirk downgraded shares of Gen-Probe (NASDAQ: GPRO) from Overweight to Neutral Monday afternoon following news of the company's $3.7 billion deal with Hologic (Nasdaq: HOLX). The analyst boosted his price target on Gen-Probe shares from $80 to $82.75.

Gen-Probe shares last traded at $81.59, up 18.7 percent from Friday's closing price.

For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Kotak Downgrades 360 ONE WAM Ltd (360ONE:IN) to Add (2)
• Truist Securities Downgrades HashiCorp Inc (HCP) to Hold
• Citi Downgrades Molson Coors (TAP) to Sell, 'Cycling 2023 Could Be a Mountain Too Hard to Climb'